Human umbilical cord mesenchymal stromal cells rescue mice from acetaminophen-induced acute liver failure

Cytotherapy

Volumn 16, Issue 9, 2014, Pages 1207-1219

  Liu, Zongcai ^a   Meng, Fanwei ^a   Li, Chan ^a   Zhou, Xin ^a   Zeng, Xiaoping ^a   He, Yixin ^a   Mrsny, Randall J ^c,d   Liu, Muyun ^a   Hu, Xiang ^a   Hu, Ji Fan ^b,c   Li, Tao ^a  

^a Shenzhen Beike Cell Engineering Research Institute   (China)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GMR Epigenetics Corporation   (United States)

^d University of Bath   (United Kingdom)

Author keywords

Acute liver failure; Anti inflammation; Antioxidants; Apoptosis; Hepatic regeneration; Umbilical cord mesenchymal stromal cells

Indexed keywords

CD45 ANTIGEN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HLA DR ANTIGEN; PARACETAMOL; SCATTER FACTOR; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ACUTE LIVER FAILURE; ADIPOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL ISOLATION; CELL TRANSPLANTATION; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER REGENERATION; MALE; MESENCHYMAL STROMA CELL; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURIFICATION; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; SURVIVAL RATE; TREATMENT RESPONSE; UMBILICAL CORD; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CELL CULTURE; CHEMICALLY INDUCED; CYTOLOGY; DISEASE MODEL; INTRAVENOUS DRUG ADMINISTRATION; LIVER; LIVER FAILURE, ACUTE; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ACETAMINOPHEN; ADMINISTRATION, INTRAVENOUS; ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; CELL DIFFERENTIATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HUMANS; LIVER; LIVER FAILURE, ACUTE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE, INBRED BALB C; UMBILICAL CORD;

EID: 84905459453     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2014.05.018     Document Type: Article

References (38)

1. Malhi H., Gores G.J., Lemasters J.J. Apoptosis and necrosis in the liver: a tale of two deaths?. Hepatology 2006, 43(2 Suppl 1):S31-44.
2. Reuben A., Koch D.G., Lee W.M. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology 2010, 52:2065-2076.
3. Lee W.M., Stravitz R.T., Larson A.M. Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011. Hepatology 2012, 55:965-967.
4. Fiegel H.C., Lange C., Kneser U., Lambrecht W., Zander A.R., Rogiers X., et al. Fetal and adult liver stem cells for liver regeneration and tissue engineering. J Cell Mol Med 2006, 10:577-587.
5. Stutchfield B.M., Forbes S.J., Wigmore S.J. Prospects for stem cell transplantation in the treatment of hepatic disease. Liver Transplant 2010, 16:827-836.
6. Enns G.M., Millan M.T. Cell-based therapies for metabolic liver disease. Mol Genet Metab 2008, 95:3-10.
7. Yuan S., Jiang T., Sun L., Zheng R., Ahat N., Zhang Y. The role of bone marrow mesenchymal stem cells in the treatment of acute liver failure. BioMed Res Int 2013, 2013:251846.
8. Buhring H.J., Treml S., Cerabona F., de Zwart P., Kanz L., Sobiesiak M. Phenotypic characterization of distinct human bone marrow-derived MSC subsets. Ann N Y Acad Sci 2009, 1176:124-134.
9. Young H.E., Steele T.A., Bray R.A., Hudson J., Floyd J.A., Hawkins K., et al. Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec 2001, 264:51-62.
10. Wang X., Sha X.J., Li G.H., Yang F.S., Ji K., Wen L.Y., et al. Comparative characterization of stem cells from human exfoliated deciduous teeth and dental pulp stem cells. Arch Oral Biol 2012, 57:1231-1240.
11. Zagoura D.S., Roubelakis M.G., Bitsika V., Trohatou O., Pappa K.I., Kapelouzou A., et al. Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure. Gut 2012, 61:894-906.
12. Cao H., Yang J., Yu J., Pan Q., Li J., Zhou P., et al. Therapeutic potential of transplanted placental mesenchymal stem cells in treating Chinese miniature pigs with acute liver failure. BMC Med 2012, 10:56.
13. Karaoz E., Okcu A., Unal Z.S., Subasi C., Saglam O., Duruksu G. Adipose tissue-derived mesenchymal stromal cells efficiently differentiate into insulin-producing cells in pancreatic islet microenvironment both in vitro and in vivo. Cytotherapy 2013, 15:557-570.
14. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418:41-49.
15. Bonanno G., Mariotti A., Procoli A., Corallo M., Rutella S., Pessina G., et al. Human cord blood CD133+ cells immunoselected by a clinical-grade apparatus differentiate in vitro into endothelial- and cardiomyocyte-like cells. Transfusion 2007, 47:280-289.
16. Rowlands A.S., George P.A., Cooper-White J.J. Directing osteogenic and myogenic differentiation of MSCs: interplay of stiffness and adhesive ligand presentation. Am J Physiol Cell Physiol 2008, 295:C1037-C1044.
17. Ng F., Boucher S., Koh S., Sastry K.S., Chase L., Lakshmipathy U., et al. PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 2008, 112:295-307.
18. Banas A., Teratani T., Yamamoto Y., Tokuhara M., Takeshita F., Osaki M., et al. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem Cells 2008, 26:2705-2712.
19. de Freitas Souza B.S., Nascimento R.C., de Oliveira S.A., Vasconcelos J.F., Kaneto C.M., de Carvalho L.F., et al. Transplantation of bone marrow cells decreases tumor necrosis factor-alpha production and blood-brain barrier permeability and improves survival in a mouse model of acetaminophen-induced acute liver disease. Cytotherapy 2012, 14:1011-1021.
20. Peng L., Xie D.Y., Lin B.L., Liu J., Zhu H.P., Xie C., et al. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes. Hepatology 2011, 54:820-828.
21. El-Ansary M., Abdel-Aziz I., Mogawer S., Abdel-Hamid S., Hammam O., Teaema S., et al. Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis. Stem Cell Rev 2012, 8:972-981.
22. Parekkadan B., van Poll D., Suganuma K., Carter E.A., Berthiaume F., Tilles A.W., et al. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PloS One 2007, 2:e941.
23. Weiss M.L., Anderson C., Medicetty S., Seshareddy K.B., Weiss R.J., VanderWerff I., et al. Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells 2008, 26:2865-2874.
24. Cho P.S., Messina D.J., Hirsh E.L., Chi N., Goldman S.N., Lo D.P., et al. Immunogenicity of umbilical cord tissue derived cells. Blood 2008, 111:430-438.
25. Byeon Y.E., Ryu H.H., Park S.S., Koyama Y., Kikuchi M., Kim W.H., et al. Paracrine effect of canine allogenic umbilical cord blood-derived mesenchymal stromal cells mixed with beta-tricalcium phosphate on bone regeneration in ectopic implantations. Cytotherapy 2010, 12:626-636.
26. Wang J., Zhou X., Cui L., Yan L., Liang J., Cheng X., et al. The significance of CD14+ monocytes in peripheral blood stem cells for the treatment of rat liver cirrhosis. Cytotherapy 2010, 12:1022-1034.
27. Zhang S., Chen L., Liu T., Zhang B., Xiang D., Wang Z., et al. Human umbilical cord matrix stem cells efficiently rescue acute liver failure through paracrine effects rather than hepatic differentiation. Tissue Eng Part A 2012, 18:1352-1364.
28. Burra P., Arcidiacono D., Bizzaro D., Chioato T., Di Liddo R., Banerjee A., et al. Systemic administration of a novel human umbilical cord mesenchymal stem cells population accelerates the resolution of acute liver injury. BMC Gastroenterol 2012, 12:88.
29. Chen M., Zhang H., Wu J., Xu L., Xu D., Sun J., et al. Promotion of the induction of cell pluripotency through metabolic remodeling by thyroid hormone triiodothyronine-activated PI3K/AKT signal pathway. Biomaterials 2012, 33:5514-5523.
30. Li T., Hu J.F., Qiu X., Ling J., Chen H., Wang S., et al. CTCF regulates allelic expression of Igf2 by orchestrating a promoter-polycomb repressive complex 2 intrachromosomal loop. Mol Cell Biol 2008, 28:6473-6482.
31. Rutherford A., Chung R.T. Acute liver failure: mechanisms of hepatocyte injury and regeneration. Semin Liver Dis 2008, 28:167-174.
32. Bantel H., Schulze-Osthoff K. Mechanisms of cell death in acute liver failure. Frontiers Physiol 2012, 3:79.
33. Christ B., Bruckner S. Rodent animal models for surrogate analysis of cell therapy in acute liver failure. Frontiers Physiol 2012, 3:78.
34. Vargas G.A., Hoeflich A., Jehle P.M. Hepatocyte growth factor in renal failure: promise and reality. Kidney Int 2000, 57:1426-1436.
35. Kaido T., Seto S., Yamaoka S., Yoshikawa A., Imamura M. Perioperative continuous hepatocyte growth factor supply prevents postoperative liver failure in rats with liver cirrhosis. J Surg Res 1998, 74:173-178.
36. Gebhardt R., Hovhannisyan A. Organ patterning in the adult stage: the role of Wnt/beta-catenin signaling in liver zonation and beyond. Dev Dyn 2010, 239:45-55.
37. van Poll D., Parekkadan B., Cho C.H., Berthiaume F., Nahmias Y., Tilles A.W., et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 2008, 47:1634-1643.
38. Yagi H., Soto-Gutierrez A., Kitagawa Y., Tilles A.W., Tompkins R.G., Yarmush M.L. Bone marrow mesenchymal stromal cells attenuate organ injury induced by LPS and burn. Cell Transplant 2010, 19:823-830.